Autophagy as a target for cancer therapy: new developments

JS Carew, KR Kelly, ST Nawrocki - Cancer management and …, 2012 - Taylor & Francis
Autophagy is an evolutionarily conserved lysosomal degradation pathway that eliminates
cytosolic proteins, macromolecules, organelles, and protein aggregates. Activation of …

[PDF][PDF] Autophagy as a target for cancer therapy: new developments

JS Carew - Cancer Management and Research, 2012 - Citeseer
Autophagy is an evolutionarily conserved lysosomal degradation pathway that eliminates
cytosolic proteins, macromolecules, organelles, and protein aggregates. Activation of …

Autophagy as a target for cancer therapy: new developments.

JS Carew, KR Kelly, ST Nawrocki - Cancer Management and …, 2012 - europepmc.org
Autophagy is an evolutionarily conserved lysosomal degradation pathway that eliminates
cytosolic proteins, macromolecules, organelles, and protein aggregates. Activation of …

Autophagy as a target for cancer therapy: new developments

JS Carew, KR Kelly… - Cancer management …, 2012 - pubmed.ncbi.nlm.nih.gov
Autophagy is an evolutionarily conserved lysosomal degradation pathway that eliminates
cytosolic proteins, macromolecules, organelles, and protein aggregates. Activation of …

Autophagy as a target for cancer therapy: new developments

JS Carew, KR Kelly… - Cancer Management and …, 2012 - search.proquest.com
Autophagy is an evolutionarily conserved lysosomal degradation pathway that eliminates
cytosolic proteins, macromolecules, organelles, and protein aggregates. Activation of …

Autophagy as a target for cancer therapy: new developments

JS Carew, KR Kelly, ST Nawrocki - Cancer Management and Research, 2012 - go.gale.com
Autophagy is an evolutionarily conserved lysosomal degradation pathway that eliminates
cytosolic proteins, macromolecules, organelles, and protein aggregates. Activation of …

[PDF][PDF] Autophagy as a target for cancer therapy: new developments

JS Carew - Cancer Management and Research, 2012 - pdfs.semanticscholar.org
Autophagy is an evolutionarily conserved lysosomal degradation pathway that eliminates
cytosolic proteins, macromolecules, organelles, and protein aggregates. Activation of …

Autophagy as a target for cancer therapy: new developments

JS Carew, KR Kelly, ST Nawrocki - Cancer Management and Research, 2012 - osti.gov
Autophagy is an evolutionarily conserved lysosomal degradation pathway that eliminates
cytosolic proteins, macromolecules, organelles, and protein aggregates. Activation of …

[HTML][HTML] Autophagy as a target for cancer therapy: new developments

JS Carew, KR Kelly, ST Nawrocki - Cancer Management and …, 2012 - ncbi.nlm.nih.gov
Autophagy is an evolutionarily conserved lysosomal degradation pathway that eliminates
cytosolic proteins, macromolecules, organelles, and protein aggregates. Activation of …

Autophagy as a target for cancer therapy: new developments

JS Carew, KR Kelly, ST Nawrocki - Cancer Management and Research, 2012 - inis.iaea.org
[en] Autophagy is an evolutionarily conserved lysosomal degradation pathway that
eliminates cytosolic proteins, macromolecules, organelles, and protein aggregates …